EpiCor® (Postbiotic Yeast Fermentate — Cargill)

Saccharomyces cerevisiae
Evidence Level
Very Strong
2 Clinical Trials
7 Documented Benefits
5/5 Evidence Score

EpiCor® is a SCIENCE-BACKED POSTBIOTIC INGREDIENT from Cargill — derived from the fermentation of Saccharomyces cerevisiae (baker's yeast). Distinguished as the #1 postbiotic ingredient globally, formulated into more products than any other postbiotic. Backed by 15+ published clinical studies. Used for: immune health, year-round immune support, cold/flu adjunct, gut-immune axis.

Studied Dose 500 mg/day EpiCor (research-validated)
Active Compound Yeast fermentate from Saccharomyces cerevisiae — beneficial mix of metabolites and bioactive compounds

Benefits

#1 Postbiotic Ingredient Globally

EpiCor is formulated into more products than any other postbiotic ingredient — established market leadership and consumer awareness.

15+ Published Clinical Studies

Robust evidence base spanning cold/flu reduction, immune marker improvements, gut-immune axis applications.

Cold and Flu Symptom Reduction

Multiple RCTs demonstrate reduced incidence and severity of cold and flu symptoms with daily EpiCor supplementation.

Year-Round Immune Support

Designed for ongoing daily use rather than acute illness intervention — supports baseline immune function.

Postbiotic Mechanism

Postbiotics provide benefits without live bacteria — heat-stable, shelf-stable, no refrigeration required, no contraindication for immunocompromised.

Children's Immune Health Research

Recently published clinical research specifically in children supporting pediatric immune health applications.

Gut-Immune Axis

Modulates gut microbiome and gut-immune communication — comprehensive immune support beyond direct effects.

Mechanism of action

1

Postbiotic Bioactive Compounds

EpiCor contains beneficial mix of metabolites, β-glucans, mannans, polyphenols, peptides, and other bioactive compounds produced during yeast fermentation.

2

Innate Immune Activation

Activates innate immune cells including NK cells, macrophages, and neutrophils — first-line immune defense.

3

sIgA Modulation

Increases secretory IgA in mucosal surfaces — primary antibody at respiratory and GI mucosal barriers.

4

Antioxidant and Anti-Inflammatory Activity

Yeast metabolites provide antioxidant and modest anti-inflammatory effects.

5

Gut Microbiome Modulation

Modulates gut microbiome composition and supports gut-immune communication.

Clinical trials

1
EpiCor for Cold/Flu Reduction — Multiple RCTs
PubMed

Multiple EpiCor 500 mg/day RCTs in healthy adults during cold/flu season.

Healthy adults across studies.

Reduced incidence and severity of cold/flu symptoms; improved respiratory health markers.

2
EpiCor in Children — Recent Research

Recently published clinical research on EpiCor in pediatric populations.

Children.

Supports pediatric immune health applications.

About this ingredient

About the active ingredient

EPICOR is a SCIENCE-BACKED POSTBIOTIC INGREDIENT from CARGILL — derived from the fermentation of SACCHAROMYCES CEREVISIAE (baker's yeast). POSTBIOTIC BACKGROUND: postbiotics are non-viable bacterial/yeast products including metabolites, cell wall components, and bioactive compounds; provide health benefits without requiring live organisms; emerging category distinct from probiotics (live) and prebiotics (food for microbes).

KEY DISTINCTIONS: (1) #1 POSTBIOTIC INGREDIENT globally; (2) 15+ published clinical studies; (3) Cargill quality and global supply; (4) Heat-stable and shelf-stable; (5) Suitable for immunocompromised (no live organisms); (6) Recent children's immune research; (7) Comprehensive gut-immune axis applications.

EVIDENCE-BASED USES: (1) Year-round immune support; (2) Cold and flu symptom reduction; (3) Pediatric immune health; (4) Gut-immune axis support; (5) Mucosal immunity (sIgA).

CRITICAL CAUTIONS: (1) YEAST ALLERGY — EpiCor derived from yeast; AVOID with yeast/mold allergy; (2) DOSE — 500 mg/day research-validated; (3) DURATION — daily supplementation; effects build over weeks-months; (4) PREGNANCY/LACTATION — generally considered safe at moderate doses; consult; (5) IMMUNOCOMPROMISED — postbiotic mechanism makes EpiCor suitable for those who cannot use live probiotics; (6) EPICOR vs LIVE PROBIOTICS — different mechanisms; postbiotics include immune-modulating compounds without live organism; complementary; (7) EPICOR vs WELLMUNE BETA-GLUCAN — both immune support; different mechanisms (yeast fermentate vs purified beta-glucan); both have evidence; (8) FOR COMPREHENSIVE IMMUNE HEALTH — sleep, exercise, stress management, nutrition (vitamin C, D, zinc), supplements adjunct; (9) BRAND VERIFICATION — EpiCor is Cargill trademark; specific yeast fermentate; clinical evidence on this branded form; (10) Among the most-evidence-based immune support ingredients globally.

Side effects and drug interactions

Common Potential side effects

Generally extremely well-tolerated.
Mild GI distress (rare).
Allergic reactions to yeast possible — relevant for those with yeast/mold allergies.
POSTBIOTIC vs PROBIOTIC — no live bacteria; suitable for immunocompromised.

Important Drug interactions

Generally minimal drug interactions.
Yeast allergy — verify if allergic to baker's/brewer's yeast.
Pregnancy — limited specific safety data; generally considered safe at moderate doses; consult.
Lactation — generally safe.
Children — established pediatric safety; appropriate at proportional doses.

Frequently asked questions about EpiCor® (Postbiotic Yeast Fermentate — Cargill)

What is the recommended dosage of EpiCor® (Postbiotic Yeast Fermentate — Cargill)?

The clinically studied dose for EpiCor® (Postbiotic Yeast Fermentate — Cargill) is 500 mg/day EpiCor (research-validated). Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is EpiCor® (Postbiotic Yeast Fermentate — Cargill) used for?

EpiCor® (Postbiotic Yeast Fermentate — Cargill) is studied for #1 postbiotic ingredient globally, 15+ published clinical studies, cold and flu symptom reduction. EpiCor is formulated into more products than any other postbiotic ingredient — established market leadership and consumer awareness.

Are there side effects from taking EpiCor® (Postbiotic Yeast Fermentate — Cargill)?

Reported potential side effects may include: Generally extremely well-tolerated. Mild GI distress (rare). Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Does EpiCor® (Postbiotic Yeast Fermentate — Cargill) interact with medications?

Known drug interactions may include: Generally minimal drug interactions. Yeast allergy — verify if allergic to baker's/brewer's yeast. Consult a pharmacist or healthcare provider if you take prescription medications.

Is EpiCor® (Postbiotic Yeast Fermentate — Cargill) good for immune support?

Yes, EpiCor® (Postbiotic Yeast Fermentate — Cargill) is researched for Immune Support support. Robust evidence base spanning cold/flu reduction, immune marker improvements, gut-immune axis applications.